← Leaderboards
Mark T. Reding
University Of Minnesota
$19,627
Attributed
$19,627
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.3K · FY2006–09$10K$7.5K$5K$2.5K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$19,627 · 4
By mechanism
M01$19,627 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Demetris Yannopoulos$17,118,162
- Bruce R. Blazar$144,460,093
- Erik Brian Finger$7,676,455
- Steven E Patterson$9,957,982
- Fang Li$9,155,528
Others in their field
Top investigators on “Hemorrhage”
- Chanza Baytop · Westat, Inc.$271,217,917
- Daniel F Hanley · Johns Hopkins University$53,423,550
- Paula Darby Lipman · Westat, Inc.$52,512,411
- Daniel Woo · University Of Cincinnati$50,047,308
- Kartik Chandran · Albert Einstein College Of Medicine$48,256,020
- Robert F Garry · Scripps Research Institute, The$45,179,770
Research focus
HemorrhageResearch PersonnelRecombinantsInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthSourceResourcesFundingGrantHemophilia AAcuteBaseBlood Coagulation FactorDoseMonitorPlasma AlbuminProphylacticQuality Of LifeQuestionnairesScheduleClinical ResearchProtocols, TreatmentDrug Kinetics
Grant awards (4)
#060201: ADVATE ANTIHEMOPHILIAC FACTOR (RECOMBINANT) PLASMA/ALBUMIN-FREE METHOD$4,756
M01 · FY2009 · RR · contact PI
#060201: ADVATE ANTIHEMOPHILIAC FACTOR (RECOMBINANT) PLASMA/ALBUMIN-FREE METHOD$9,276
M01 · FY2008 · RR · contact PI
AN OPEN-LABEL STUDY OF THE HEMOSTATIC ACTIVITY, PHARMACOKINETICS AND SAFETY OF O$5,237
M01 · FY2007 · RR · contact PI
AN OPEN-LABEL STUDY OF THE HEMOSTATIC ACTIVITY, PHARMACOKINETICS AND SAFETY OF O$358
M01 · FY2006 · RR · contact PI